n-(3-(aminomethyl)benzyl)acetamidine has been researched along with ANS (Autonomic Nervous System) Diseases in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egi, K | 1 |
| Conrad, NE | 1 |
| Kwan, J | 1 |
| Schulze, C | 1 |
| Schulz, R | 1 |
| Wildhirt, SM | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts.
Topics: Amidines; Animals; Autonomic Nervous System Diseases; Benzylamines; Dose-Response Relationship, Drug | 2004 |